RCT | Mindfulness-based stress reduction vs. escitalopram for the treatment of adults with anxiety disorders.
10 Nov, 2022 | 14:09h | UTCMindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial – JAMA Psychiatry (free for a limited period)
Commentaries:
Mindfulness worked as well for anxiety as drug in study – Associated Press
Meditation works as well as a popular drug to reduce anxiety, study finds – NPR
Commentary on Twitter
This randomized, controlled #anxiety disorder treatment trial comparing a standardized, evidence-based mindfulness-based intervention with pharmacotherapy and found that mindfulness based stress reduction was non-inferior to escitalopram https://t.co/P7KJQlT03g
— JAMA Psychiatry (@JAMAPsych) November 9, 2022